R. John Fletcher - 21 May 2021 Form 4 Insider Report for Vyant Bio, Inc.

Role
Director
Signature
/s/ Andrew LaFrence, attorney-in-fact
Issuer symbol
N/A
Transactions as of
21 May 2021
Net transactions value
+$101,783
Form type
4
Filing time
24 May 2021, 16:05:37 UTC
Previous filing
18 May 2021
Next filing
28 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNT Common Stock, $0.0001 par value Purchase $49,948 +15,000 $3.33 15,000 21 May 2021 By R. John Fletcher 2015 Revocable Trust F1
transaction VYNT Common Stock, $0.0001 par value Purchase $51,835 +15,300 +102% $3.39 30,300 24 May 2021 By R. John Fletcher 2015 Revocable Trust F2
holding VYNT Common Stock, $0.0001 par value 8,676 21 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.31 to $3.34 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.33 to $3.47 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.